Últimas noticias sobre Profound Medical (NASDAQ:PROF) Bolsa

Profound Medical

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Pinterest,Mobile,App,On,The,Screen,Smartphone,Iphone,Closeup.,Pinterest

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

CETY

CRVS

FIGS

GDOT

GMED

IOVA

JBIO

NCNA

PINS

PROF

SHPH

TMDX

VEEE

WOLF

WORX

ZKIN

Pinterest sube un 12,7 % tras superar ingresos del primer trimestre y aumentar usuarios mensuales. Otras acciones también reaccionan.

Acciones de Pinterest (PINS) se disparan un 13%; Aquí están 20 acciones que se mueven en el premercado

Press Releases

Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow

Legal

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Profound Medical Corp. - PROF

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy

Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference

Earnings

Profound Medical Announces First Quarter 2025 Financial Results

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®

Health Care

General

Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction

Comments

Profound Medical

Noticias

Últimas noticias sobre Profound Medical (NASDAQ:PROF) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL